TL;DR
This paper introduces a novel "beam-specific" optimization target volume (OTV<sub>WET</sub>) for proton therapy in pancreatic cancer. This method offers a more efficient and robust approach to accounting for treatment uncertainties compared to traditional uniform expansion or complex "robustness optimization" techniques, leading to comparable target coverage with improved OAR sparing.
What Problem Does This Paper Address?
Delivering precise radiation therapy, especially for challenging targets like locally advanced pancreatic cancer, is crucial for maximizing treatment efficacy while minimizing damage to surrounding healthy tissues. Proton therapy, with its unique dose deposition properties, offers potential advantages, but its accuracy is highly sensitive to uncertainties in patient setup and the proton beam's range in tissue. Traditional methods for accounting for these uncertainties, such as simply expanding the target volume uniformly, can lead to either under-dosing the target or unnecessarily irradiating nearby organs at risk (OARs). More advanced "robustness optimization" (RO) methods can achieve better results but are computationally intensive, making them less practical for real-time adaptive therapy. This paper addresses the need for a planning method that balances target coverage, OAR sparing, and computational efficiency in the context of proton pencil beam scanning (PBS) for pancreatic cancer.
Methods
The researchers compared three approaches for defining the optimization target volume (OTV):
- OTV<sub>2mm</sub>: A simple, uniform 2 mm expansion around the gross tumor volume (GTV). This is a standard approach to account for setup uncertainties.
- OTV<sub>WET</sub>: A novel "beam-specific" expansion. This method considers the water-equivalent thickness (WET) along the beam path, expanding the target volume differently in the beam direction (to account for range uncertainties) and laterally (for setup uncertainties). This approach aims to create a more tailored margin.
- Robustness Optimization (RO): A more complex method that accounts for a wide range of potential setup and range uncertainties by optimizing the plan across multiple "scenarios" without explicitly defining an OTV. This serves as a benchmark for robustness.
Six patients with locally advanced pancreatic cancer were planned using these three methods, with a prescribed dose of 33 Gy (RBE) in 5 fractions. The plans were evaluated for target coverage (specifically, the percentage of the GTV receiving at least 100% of the prescribed dose) and OAR sparing, particularly for the duodenum, which is in close proximity to the pancreas.
Datasets
The study utilized data from six patients diagnosed with localized, advanced pancreatic adenocarcinoma who underwent SBRT with an active breath control technique. The GTV and OARs were contoured by physicians. No new datasets were introduced.
Key Insights and Ideas
- Beam-specific margins are more intelligent: The OTV<sub>WET</sub> method, by considering the specific path of the proton beam and its interaction with tissue, offers a more refined way to account for uncertainties than a simple uniform expansion.
- Robustness vs. Efficiency Trade-off: While RO provides the most robust plans against uncertainties, it comes at a significant computational cost. OTV<sub>WET</sub> offers a compelling middle ground, achieving comparable robustness to RO with much faster planning times.
- OTV<sub>2mm</sub> is too simplistic for this scenario: The uniform 2 mm expansion proved to be insufficient for robustly covering the target under simulated uncertainties, leading to a high failure rate in meeting coverage goals.
- OTV<sub>WET</sub> mimics RO's union volume: The OTV<sub>WET</sub> approach effectively acts like a union of all possible scenarios considered in RO, but in a more computationally efficient manner.
- Implications for Adaptive Therapy: The efficiency of OTV<sub>WET</sub> makes it particularly attractive for online adaptive stereotactic body proton therapy, where rapid replanning is essential.
Key Results
- Target Coverage: All three schemes achieved decent target coverage. However, OTV<sub>2mm</sub> plans showed a significantly lower passing rate (19%) for meeting the goal of 95% of the GTV receiving 100% of the prescribed dose when subjected to simulated uncertainties, compared to 100% for OTV<sub>WET</sub> and RO.
- OAR Sparing: OTV<sub>2mm</sub> plans demonstrated superior sparing of OARs, especially the proximal duodenum, due to their smaller margins. OTV<sub>WET</sub> plans showed inferior sparing of the small bowel compared to the other two.
- Robustness: RO plans were the most forgiving to uncertainties. OTV<sub>WET</sub> plans were also robust, showing less degradation in quality compared to OTV<sub>2mm</sub>. OTV<sub>2mm</sub> plans were highly susceptible to range and setup uncertainties.
- Computational Efficiency: OTV<sub>WET</sub> planning took about half an hour, while RO planning could take up to 2 hours, highlighting a significant time-saving advantage for OTV<sub>WET</sub>.
Limitations and Future Work
- Beam Angle Optimization: The study did not implement optimization of beam angles, which is acknowledged as playing an essential role in plan quality.
- DSF Region of Interest: The selection of the region of interest for the dose spread function (DSF) analysis was limited to the abutment of the 100% isodose line and the duodenum. Future work could explore optimizing this region.
- Range Uncertainty Estimation: The WET calculation was based on single-energy CT images, introducing an estimated 3.5% uncertainty. Future studies could explore dual-energy CT (DECT) to potentially reduce this uncertainty to 2%.
- Hydrogel Integration: The paper mentions the potential of novel biodegradable hydrogels for separating the pancreas from the duodenum to further reduce toxicity. Correlating the amount of injected hydrogel with dosimetric consequences and optimizing its use remains a future direction.
- Further Investigation of OTV<sub>WET</sub>: While OTV<sub>WET</sub> shows promise, further investigation into its application for online adaptive stereotactic body proton therapy is suggested.
Summary updated